Nanavati Max Super Speciality Hospital Revenue and Competitors
Employee Data
- Nanavati Max Super Speciality Hospital has 980 Employees.
- Nanavati Max Super Speciality Hospital grew their employee count by 5% last year.
Nanavati Max Super Speciality Hospital's People
Name | Title | Email/Phone |
---|---|---|
1 | General Manager Sales Marketing | Reveal Email/Phone |
2 | Executive, Clinical Pharmacist | Reveal Email/Phone |
Nanavati Max Super Speciality Hospital Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 980 | 5% | N/A | N/A |
What Is Nanavati Max Super Speciality Hospital?
Nanavati Max Super Speciality Hospital has been at the forefront of healthcare for 65 years. Today the 350 bed facility housing 55 speciality departments offers a plethora of services in practically every field of modern medicine and health care. Our well-equipped hospital rooms, state-of-the-art departments and technologically advanced systems are all backed by the expertise and reputation of over 350 consultants, 100 resident doctors, 475 nursing staff and 1500 employees. The hospital’s state-of-the-art Imaging Centre, spanning over 10,000 sq. ft, houses 3 Tesla 32 channel wide bore Magnetic Resonance Imaging (MRI) scanner with MR guided Focused Ultrasound Surgery (MRgFUS) and High-Intensity-Focused-Ultrasound, 64 slice Positron Emission Tomography–Computed Tomography (PET CT) with cardiac capability. The Catheterization Lab at Nanavati Heart Centre which is the first of its kind in Mumbai, has a team of highly experienced and qualified faculty providing 24x7 Interventional Cardiac Services. Emergency : +91 22 26 26 77 77 Board line : +91 22 2626 7500
keywords:N/AN/A
Total Funding
980
Number of Employees
N/A
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $144.1M | 980 | 11% | N/A |
#2 | $141.7M | 981 | 10% | $75M |
#3 | N/A | 983 | 5% | N/A |
#4 | $283.6M | 988 | 10% | N/A |
#5 | N/A | 999 | 11% | N/A |